Supplementary Figure from Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer

Autor: Marta Martins, Luís Costa, Rita Fior, André Mansinho, Ana Lucia-Costa, Catarina Abreu, Teresa R. Pacheco, Maria J. Brito, Helder Mansinho, Ana R. Miranda, Miguel Godinho Ferreira, Ana T. Xavier, José Vílchez, João Gramaça, Daniel Machado, Lina M. Gallego-Paez, Daniel Sobral, Paula Borralho, Afonso Fernandes, Magda Negrão, Cátia Rebelo de Almeida, Raquel Cruz-Duarte

Supplementary Figure from Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083ae1169e4cc776a94303306d7877c5
https://doi.org/10.1158/1078-0432.22484019

Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer

Autor: Raquel Cruz-Duarte, Cátia Rebelo de Almeida, Magda Negrão, Afonso Fernandes, Paula Borralho, Daniel Sobral, Lina M. Gallego-Paez, Daniel Machado, João Gramaça, José Vílchez, Ana T. Xavier, Miguel Godinho Ferreira, Ana R. Miranda, Helder Mansinho, Maria J. Brito, Teresa R. Pacheco, Catarina Abreu, Ana Lucia-Costa, André Mansinho, Rita Fior, Luís Costa, Marta Martins

Publikováno v: Clinical Cancer Research
Clinical Cancer Research, American Association for Cancer Research, 2022, pp.clincanres.1992.2021. ⟨10.1158/1078-0432.CCR-21-1992⟩

© 2022 The Authors; Published by the American Association for Cancer Research. This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 International (CC BY-NC-ND)
Purpose: Cetuximab is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8c83eb18a02ddfbb46b4b0884da178
https://doi.org/10.1158/1078-0432.ccr-21-1992